ProCE Banner Series

Integrating Emerging Insights Into Clinical Practice: Expert Roundtable on Immunotherapy Advances in Colorectal Cancer From the Gastrointestinal Cancers Symposium

Join us for this interactive, CME-certified live webinar featuring expert perspectives on the use of immunotherapy for early- and advanced-stage colorectal cancer, with a focus on recent practice-changing studies. Be sure to bring your questions for the live Q&A session with the expert panel. 

  AMA
Who Should Attend

This activity is intended for medical oncologists and other healthcare professionals who care for patients with colorectal cancer.

All Events

Integrating Emerging Insights Into Clinical Practice: Expert Roundtable on Immunotherapy Advances in Colorectal Cancer From the Gastrointestinal Cancers Symposium

Upcoming Events

February

24

2025

12:00 PM - 1:00 PM Eastern Time (ET)

Virtual

Topics

Gastrointestinal cancer
Colorectal cancer

Additional Info

There are no fees required to participate in this activity.

Americans With Disabilities Act
Event staff will be glad to assist you with any special needs (eg, physical, dietary). Please contact Customer Support prior to the live event.

CME/CE Info

Goal Statement
The goal of this activity is to improve the knowledge and competence of learners in effort to optimize treatment for patients with colorectal cancer (CRC).

Target Audience
This activity is intended for medical oncologists and other healthcare professionals who care for patients with colorectal cancer.

Learning Objectives
Upon completion of this activity, participants should be able to:

  •  Integrate ICIs into the treatment of colorectal cancer throughout the disease continuum

  • Identify patients with colorectal cancer eligible for ICI therapy based on expert recommendations, evidence, and patient and disease factors

  • Formulate evidence-based strategies for the selection and sequencing of ICI-based treatments after progression on first-line therapy in colorectal cancer

  • Use expert recommendations to identify and manage irAEs associated with ICI-based therapy

Accreditation

Joint Accreditation Statement

In support of improving patient care, Clinical Care Options, LLC (CCO) is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.

Physician Continuing Medical Education

CCO designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

CME Passport

https://omni-channel-2022-assets-production.s3.amazonaws.com/editorupload/662be69741e7b.png

The CME credits that physicians earn from this activity will be submitted to ACCME's CME Passport, a free, centralized web application where you can create a personalized account to view, track, and generate transcripts of your reported CME credit. Visit www.cmepassport.org to create your account.

Disclosure of Conflicts of Interest
Clinical Care Options, LLC (CCO) requires instructors, planners, managers, and other individuals who are in a position to control the content of this activity to disclose all financial conflicts of interest (COI) they may have with ineligible companies. All relevant COI are thoroughly vetted and mitigated according to CCO policy. CCO is committed to providing its learners with high-quality CME/CE activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of an ineligible company.

Acknowledgement

Provided by Clinical Care Options, LLC

This educational activity is supported by an independent medical education grant from GSK.